DYN

NASDAQ 已收盘

Dyne Therapeutics

16.03 USD
▲+0.16+1.01%
盘后 15.98 -0.31%
2026-11-19
市值
$2.99B
市盈率
—
EPS
-3.67
股息率
—
52 周区间
14.00 – 27.31
成交量
2.44M
Beta
1.21
目标价
34.33
52W 低 14.0052W 高 27.31
价格走势

公司简介

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incor...

关联新闻